+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease

, : Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease. Neuroreport 27(15): 1114-1119

As a progressive age-related neurodegenerative disorder, Alzheimer's disease (AD) is a global health concern. Despite the availability of psychological testing, neuroimaging, genetic testing, and biochemical assays of cerebrospinal fluid, convenient and accurate blood biomarkers for the prediction, diagnosis, and preclinical studies of AD are still lacking. The present study aims to longitudinally evaluate the feasibility of β-amyloid proteins, α2-macroglobulin (α-2M), complement factor H (CFH), and clusterin as blood biomarkers of AD. Using APP/PS1 transgenic and wild-type mice, cognitive impairment and amyloid plaque counts in the brain were evaluated over a range of ages using the Morris water maze test and immunohistochemistry methods, respectively. Serum Aβ40, Aβ42, α-2M, CFH, and clusterin levels were measured by enzyme-linked immunosorbent assay and correlated with progression of AD. APP/PS1 transgenic mice presented progressive AD characteristics at the ages of 3, 6, 9, and 12 months. Serum Aβ42 levels and Aβ42/Aβ40 ratios increased significantly in transgenic 3- and 6-month-old mice compared with controls. Serum CFH levels decreased significantly in 3- and 6-month-old transgenic mice compared with controls. Meanwhile, serum clusterin levels increased significantly in 12-month-old transgenic mice compared with controls. The α-2M level was not significantly different between transgenic and wild-type mice. The APP/PS1 transgenic mouse is a model of familial AD. The present study indicated that the serum Aβ42 level, Aβ42/Aβ40 ratio, and CFH level are potential biomarkers in preclinical and early stages of AD, whereas serum clusterin level is a potential biomarker in the late stage of AD.


PMID: 27541273

DOI: 10.1097/WNR.0000000000000661

Other references

Mehlum, I.Sivesind.; Kjuus, H.; Veiersted, K.Bo.; Wergeland, E., 2006: Self-reported work-related health problems from the Oslo Health Study. Lack of knowledge about the occurrence of work-related health problems in the general population makes it difficult to estimate the potential for their prevention in the workplace. To examine the prevalence of self-reported work-related health pro...

Azuma, H.; Hayashi, T.; Dent, J.A.; Ruggeri, Z.M.; Ware, J., 1993: Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. von Willebrand factor (vWF) is a multimeric glycoprotein of plasma and the subendothelial matrix that interacts with specific platelet receptors to establish platelet adhesion at a site of vascular injury. The vWF domain containing the platelet re...

Kamienska-Zyla, Maria., 1965: The behaviour of the Potato virus X protein in electrophoresis. The virus was easily separated from crude plant extracts by paper electrophoresis when the sample was applied at the centre of the strip. The direction of migration of the virus in the electrical field depended occasionally on the position of the...

Labus, M.B.; Coull, J.J.; Dacanay, A.; Melvin, W.T.; Andrade-Salas, O.; Munro, A.L., 1996: Identification and expression of antigens from Lepeophtheirus salmonis for use in vaccination trials. Biochemical Society Transactions 24(2): 254s-254s

Chigir, A.A., 1975: On giving a qualification of "The Best First Aid Feldsher". Fel'dsher i Akusherka 40(2): 39-42

Ashcraft, E.W.; Casey, P.H.; Nosal, T., 1989: Intervention services for developmentally delayed infants and toddlers in Arkansas. Journal of the Arkansas Medical Society 86(5): 191-193

Parsons, R.J.; Barnes, J.G.; Higley, H.B., 1988: The community health center in a changing health care environment: the price of survival. Health Marketing Quarterly 6(4): 127-135

Wilson Charles W.J.; Tiedemann Herbert A.; Stearns Richard G., 1968: Meteor impact as a model for Wells Creek Basin cryptoexplosive structure, Tennessee. Special Paper - Geological Society of America Pages 241

Pichler, G.; Leonhardt, H.; Rothbauer, U., 2012: Fluorescent protein specific Nanotraps to study protein-protein interactions and histone-tail peptide binding. Fluorescent proteins are widely used to study protein localization and protein dynamics in living cells. Additional information on peptide binding, DNA binding, enzymatic activity, and complex formation can be obtained with various methods includi...

Wadman, M., 1997: Ethical terms set for breast cancer test. The London-based company Cancer Research Campaign Technology and its U.S. partner, Duke University in Durham, North Carolina, have been granted conditional British patent rights to a gene linked with breast cancer. The license to use the genetic d...